Accessed - 440 times.

Neha Mishra*, Pushpendra Jain.
IIMT College of Pharmacy, Greater Noida, Uttar Pradesh, India.

REVIEW ARTICLE
Volume 10, Issue 2, Page 82-87.

*Author for correspondence
E-mail: mishraneha179506@gmail.com

DOI: https://doi.org/10.5281/zenodo.7047439.

ABSTRACT
Transdermal patches are now widely used as cosmetic, topical, and transdermal delivery systems. These patches represent a key outcome of the expansion in skin science, technology, and expertise developed through trial and error, clinical observation, and evidence-based studies that go back to the first existing human records. transcutaneous delivery provides variety one edge over injectables and oral routes by increasing patient compliance and avoiding initial pass metabolism severally. transcutaneous delivery not solely provides controlled, constant administration of the drug, but additionally permits continuous input of drugs with short biological half-lives and eliminates periodical entry into circulation, which regularly causes undesirable side effects. Ciprofloxacin may be a very popular fluoroquinolone having a broad spectrum of activity and diverse therapeutic prospects. the explanations for its wide use include multiseriate pathogens susceptible only to ciprofloxacin. The available clinical evidence suggests the doubtless enhanced efficacy of this drug in the treatment of various community-acquired and nosocomial infections, e.g. skin infections, and sexually transmitted diseases. As compared to other agents of its class, the pharmacokinetic profile of ciprofloxacin demonstrates equivalent or greater bioavailability, higher plasma concentrations, and increased tissue penetration, as reflected within the greater volume of distribution. The aim of the present review is to explore the importance and utilization of Transdermal patches of Ciprofloxacin hydrochloride begins with the earliest topical therapies and traces topical delivery to the present-day transdermal patches, describing along the way the initial trials, devices, and drug delivery systems that underpin current transdermal patches and their actives.
Keywords: Transdermal delivery systems, Transdermal patch, Ciprofloxacin hydrochloride, Conventional dosage forms.